Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria

BACKGROUND: Chronic spontaneous urticaria (CSU) negatively impacts patient quality of life and productivity and is associated with considerable indirect costs to society. OBJECTIVE: The aim of this study was to assess the cost utility of add-on omalizumab treatment compared with standard of care (SO...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmacoeconomics
Asıl Yazarlar: Graham, Jonathan, McBride, Doreen, Stull, Donald, Halliday, Anna, Alexopoulos, Stamatia Theodora, Balp, Maria-Magdalena, Griffiths, Matthew, Agirrezabal, Ion, Zuberbier, Torsten, Brennan, Alan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2016
Konular:
Original Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4929169/
https://ncbi.nlm.nih.gov/pubmed/27209583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-016-0412-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller